Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
SYNTEX PROJECTS OTC NAPROSYN WILL HAVE THREE YEARS OF LOSSES
Jun 15 1992
•
By
The Pink Sheet
More from Archive
More from Pink Sheet